• Home
  • Products
    • MucoHealth™
    • PeriHealth™
    • NuBone™
  • About us
    • Our Mission
    • Our Philosophy
    • Our Company
  • News
  • Contact
  • Sustainability for Corticalis
  • Innovation for Corticalis
  • Awards and Recognitions
  • Privacy
  • Instructions For Use (IFU)
  • Scientific Literature & Clinical Studies

Who we are

Corticalis AS was founded in 2006 by leading researchers and clinicians with deep expertise in dental implants and regenerative therapies.

The company has developed innovative products for the prevention, treatment and maintenance of teeth and dental that are prone to gum disease such as peri-implant mucositis and peri-implantitis. We have also developed a nature-mimicking, non-animal product for surgically rebuilding supportive tissue around teeth and implants where it has been lost due to disease.

All our solutions are created with a strong focus on patient comfort and clinical effectiveness. We are also committed to reducing the global reliance on antibiotics by offering proven alternatives to antibiotic-based antimicrobial treatments, helping to combat the rise of resistant bacteria.

Our products will be marketed through a global network of established distributors.

Over the years, Corticalis has received strong recognition and support from the Research Council of Norway and the European Union. The European Commission has awarded us the prestigious Seal of Excellence three times, underscoring the quality and societal value of our work.

Who we are

Corticalis AS was founded in 2006 by leading researchers and clinicians with deep expertise in dental implants and regenerative therapies.

The company has developed innovative products for the prevention, treatment and maintenance of teeth and dental that are prone to gum disease such as peri-implant mucositis and peri-implantitis. We have also developed a nature-mimicking, non-animal product for surgically rebuilding supportive tissue around teeth and implants where it has been lost due to disease.

All our solutions are created with a strong focus on patient comfort and clinical effectiveness. We are also committed to reducing the global reliance on antibiotics by offering proven alternatives to antibiotic-based antimicrobial treatments, helping to combat the rise of resistant bacteria.

Our products will be marketed through a global network of established distributors.

Over the years, Corticalis has received strong recognition and support from the Research Council of Norway and the European Union. The European Commission has awarded us the prestigious Seal of Excellence three times, underscoring the quality and societal value of our work.

   Discover more about:

Our Mission Our Philosophy Our Company
Our Mission
Our Philosophy
Our Company
Our Mission
Our Philosophy
Our Company

Developed by Hjemmesidehuset  |  Privacy policy